Company: VREOF
Filing Date: 2025-05-09
Form Type: DEF 14A
Source: 0001140361-25-018064
Chunk: 67

Company: Vireo Growth Inc.
Filing Date: 2025-05-09
Form: DEF 14A
Chunk 67
---
 the sending thereof to each director of Vireo, each Shareholder entitled to Notice of Meeting to which this Circular relates and to the auditors of Vireo has been approved by the Board. DATED May 9, 2025.

| BY ORDER OF THE BOARD OF DIRECTORS                                    |
| /s/John Mazarakis                                                     |
| Name: John Mazarakis                                                  |
| Title: Chief Executive Officer and Co-Executive Chairman of the Board |

41

TABLE OF CONTENTS

SCHEDULE “A” CHARTER OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF VIREO HEALTH INTERNATIONAL, INC.

| 1. | ROLE AND OBJECTIVE |

The Audit Committee (the “ Committee”) is appointed by and reports to the board of directors (the “ Board”) of Vireo Health International, Inc. (the “ Company”). The Committee assists the Board in fulfilling its oversight responsibilities relating to accounting and financial reporting processes and internal controls for the Company and the audits of its financial statements, and in ensuring the adequacy and effectiveness of the Company’s risk management programs. The Committee members must, to the best of their abilities and knowledge and acting reasonably, meet all applicable legal, regulatory and listing requirements, including, without limitation, those of any stock exchange on which the Company’s shares are listed and the Business Corporations Act (British Columbia) (the “ BCBCA”), and all applicable securities regulatory authorities.

| 2. | COMPOSITION |

| • | The Committee is composed of three or more directors, as designated by the Board from time to time. |

| • | All members of the Committee must qualify as “independent” and all must be financially literate (as such terms are defined under applicable securities laws, the BCBCA and exchange requirements for audit committee purposes). One member of the Committee should qualify as an “audit committee financial expert” under Section 407 of the U.S. Sarbanes-Oxley Act of 2002. |

| • | Each member of the Committee must be able to read and understand fundamental financial statements, including a company’s balance sheet, income statement and cash flow statement. |

| • | Members of the Committee may not accept directly or indirectly any consulting, advisory, or other compensatory fee from the Company or any subsidiary thereof, provided that, unless the rules of the exchange on which the Company’s shares are listed provide otherwise, compensatory fees do not include the receipt of fixed amounts of compensation under a retirement plan (including